SHBG and metabolic dysfunction-associated steatotic liver disease: Thus, adipose tissue insulin resistance associated with cellular inflammatory factors negatively affect hepatic production of SHBG and accelerate metabolic and reproductive disorders, such as NAFLD/NASH, PCOS and type 2 diabetes.